MSKCC 10th Annual MSK Symposium on Lymphoma 2026

Description

Include:  videos +  file sub vtt +  pdfs, size:  GB

Target Audience: internists, hematologists, medical and radiation oncologists, hematopathologists

Join us for the 10th anniversary edition of the MSK Symposium on Lymphoma, marking a decade of advances in lymphoma diagnosis, management, and therapy. This one-and-a-half-day symposium will explore the rapidly evolving landscape of lymphoma research and clinical practice, highlighting advances in disease biology, diagnostic approaches, and therapeutic strategies that are transforming patient outcomes.

The program offers a comprehensive review of the clinical management of both common and emerging lymphoma subtypes. Through expert-led lectures, interactive panel discussions, and practical clinical guidance, faculty will share the latest evidence and insights to support informed, individualized decision-making in an era of accelerating innovation. Key highlights include:

• Keynote Lectures: Presented by internationally recognized leaders in lymphoma biology, translational research, and clinical care.
• Interactive Panel Discussions: Case-based conversations addressing evolving treatment paradigms and real-world clinical challenges.
• Allied Health Professionals Session: A dedicated session for the interprofessional care team, highlighting their essential and expanding role in lymphoma management. Please note that space is limited for this session.

Participants will gain insight into the scientific advances shaping lymphoma biology and pathology, and how these discoveries are being translated into clinical practice. This program brings together distinguished experts from MSK and institutions across the United States and around the world to advance education, collaboration, and patient-centered care—helping to shape the future of lymphoma care.

Course Date: Friday, April 10, 2026, 8:00 AM – Saturday, April 11, 2026, 2:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Learning Objectives

1. Describe recent advances in lymphoma diagnosis, helping navigate with recent advances in the WHO and ICC classifications
2. Discuss first line treatment options in most frequent lymphoma entities
3. Describe new agents mode of actions, efficacy, side effects
4. Discuss options and recommendations for patients in the relapse refractory setting
5. Provide strategies to help shared decision-making with patients regarding their treatment

Target Audience

This symposium is designed for internists, hematologists, medical and radiation oncologists, hematopathologists, scientists, and medical trainees who are involved in the diagnosis, treatment, and biomedical research of lymphoma. Participants have the option to attend in person or virtually.

Topics

1. A “Path” Toward Diagnosis- An Overview of Pathology in Lymphoma

2. Advances in Therapeutic Strategies for Mantle Cell Lymphoma

3. Bridging, Debulking, and Beyond- The Multifaceted Role of Radiotherapy with CAR T Cells and Bispecifics

4. CAR T-Cell Therapy- Lessons Learned from the DESCAR-T Registry

5. Concepts and Controversies in Aggressive B-Cell Lymphoma Classification

6. Current Challenges in the Management of Patients with Follicular Lymphoma

7. Debate- Is a Follicular Lymphoma Cure in Reach- T-Cell Engagers versus CAR T-Cell Therapy

8. Diffuse Large B-Cell Lymphoma- Diagnosis and Updates on Management

9. Diffuse Large B-Cell Lymphoma Panel Discussion and Q&A

10. Follicular Lymphoma Panel Discussion and Q&A

11. Hodgkin Lymphoma Panel Discussion and Q&A

12. HTLV-1 Clinic Overview

13. HTLV-1-Associated Lymphoma-Leukemia- Biology

14. HTLV-1-Associated Lymphoma-Leukemia- Epidemiology and Natural History

15. HTLV-1-Associated Lymphoma-Leukemia- Therapies

16. Innovations in T-Cell Lymphoma- A Winding Road

17. Insights into the Molecular Classification of Diffuse Large B-Cell Lymphoma

18. Integrative Medicine- Management of Treatment Related Side Effects

19. Introduction to Cutaneous T-Cell Lymphoma

20. Lessons Learned from the Development of T-Cell-Engaging Antibodies in B-Cell Lymphoma

21. Mantle Cell Lymphoma Panel Discussion and Q&A

22. Mechanisms of Resistance to BTK Degraders

23. Optimizing First-Line Therapy- Balancing Efficacy versus Toxicity

24. Optimizing First-Line Therapy in Diffuse Large B-Cell Lymphoma

25. Panel Discussion and Q&A

26. Plenary Lecture- Designing the Next Generation of CAR T-Cell Therapies for Lymphoma

27. Plenary Lecture Panel Discussion and Q&A

28. Recent Advances in the Management of Chronic Lymphocytic Leukemia

29. Research Spotlight- Bispecific B Cell Protocols at MSK and CRS management

30. Skin Considerations for Cutaneous T-Cell Lymphoma

31. Small Doses, Big Impact- The Role of Very Low-Dose Radiotherapy in Potentially Curable Indolent Lymphomas

32. Special Lecture- B-Cell Development and Lineage Stability

33. Special Lecture- How to Interpret “Real-World” Data

34. Spotlight on New Agents and MSK Clinical Trials

35. Spotlight on Nodular Lymphocyte Predominant B-Cell- Hodgkin Lymphoma

36. Spotlight on Recent Drugs and MSK Clinical Trials – 01

37. Spotlight on Recent Drugs and MSK Clinical Trials

38. T-Cell Lymphoma Panel Discussion and Q&A